
Melanoma antigen family A identified by the bimodality index defines a subset of triple negative breast cancers as candidates for immune response augmentation
Keywords: درمان ایمنی; Bimodal expression; Immune therapy; CT-X antigens; Prognostic markers; Subtypes of breast cancer; Microarray analysis